Eyenuk

Focus: Eyenuk is an AI-driven eye screening company focused on diabetic retinopathy detection and broader retinal imaging applications. The company operates as a specialized biotech leveraging artificial intelligence for point-of-care ophthalmology diagnostics.

Ophthalmology

Profile data last refreshed 15h ago · AI intelligence enriched 2w ago

Open Jobs

About Eyenuk

AI assessmentNot Hiring

No open roles listed right now. Follow Eyenuk to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

6 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Color fundus photography

Diabetic Retinopathy

N/A

Clinical Trials (1)

NCT03078231Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

N/A

Help build intelligence for Eyenuk

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused mission in high-prevalence disease: diabetic retinopathy affects millions globally, creating sustained demand for screening solutions.
AI/ML-first approach positions you at the intersection of healthcare and technology innovation, a rare differentiator in traditional biotech.
Established company (founded 1996) with clinical validation pathway, reducing early-stage biotech risk.

Watch Out For

No active job openings reported—hiring appears stalled or not currently active, limiting near-term entry points.
Sparse public pipeline maturity: only 1 Phase 1 trial visible and 5 non-phased programs, suggesting limited near-term clinical catalysts or revenue inflection.
Missing critical financial and funding data obscures cash runway, growth trajectory, and long-term stability.

Generated by Claude from Eyenuk's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Color fundus photography

Diabetic Retinopathy

N/A

Clinical Trials (1)

NCT04302012Assessment of EyeArt Performance With Retinal Imaging Devices

N/A

Color fundus photography

Diabetic Retinopathy

N/A

Clinical Trials (1)

NCT03112005Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

N/A

Diabetic Retinopathy screening Point of Care Artificial Intelligence

Diabetic Retinopathy (DR)

N/A

Clinical Trials (1)

NCT06721351Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence

N/A

Retinal imaging

Diabetic Retinopathy

N/A

Clinical Trials (1)

NCT04984200Assessment of EyeArt Performance With Retinal Cameras

N/A

Retinal fundus photography

Mild Cognitive Impairment

Phase 1

Clinical Trials (1)

NCT04567745Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 1996

Portfolio: 6 clinical trials

Top TAs: Ophthalmology, Neurology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Ophthalmology

5 pipeline

Neurology

1 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles